A 48-year-old man from Tamil Nadu presents with a 4-month history of progressive left-sided conductive hearing loss and aural fullness. Otoscopy reveals a dull tympanum with fluid level. Flexible nasopharyngoscopy shows a large, ulcerated mass in the nasopharynx with cervical lymphadenopathy (2.5 cm node on the left). Imaging confirms a 4 cm nasopharyngeal mass with left cervical lymph node involvement. According to the AJCC TNM staging system, what is the most likely stage of this nasopharyngeal carcinoma?

Explanation

## TNM Staging of Nasopharyngeal Carcinoma (AJCC 8th Edition) ### Clinical Assessment of This Patient **Key Point:** This patient has: - **T stage:** T3 (tumor extends beyond nasopharynx to oropharynx, nasal cavity, or infratemporal fossa) - **N stage:** N1 (unilateral cervical lymph node ≤6 cm, above the supraclavicular fossa) - **M stage:** M0 (no distant metastases) - **Overall Stage:** Stage III (T3N1M0) **Clinical Pearl:** The conductive hearing loss with fluid level (serous otitis media) is a classic sign of nasopharyngeal mass obstructing the Eustachian tube orifice. This finding, combined with the large ulcerated mass and cervical lymphadenopathy, indicates locally advanced disease. ### AJCC TNM Staging for Nasopharyngeal Carcinoma | T Stage | Definition | |---|---| | T1 | Tumor confined to nasopharynx, or extends to oropharynx and/or nasal cavity without parapharyngeal extension | | T2 | Tumor with parapharyngeal extension | | T3 | Tumor extends to bony structures of skull base and/or paranasal sinuses | | T4 | Tumor with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or infratemporal fossa | | N Stage | Definition | |---|---| | N0 | No regional lymph node metastasis | | N1 | Unilateral cervical lymph node(s) ≤6 cm, above supraclavicular fossa | | N2 | Bilateral cervical lymph node(s) ≤6 cm, above supraclavicular fossa; or single/multiple unilateral/bilateral nodes >6 cm but ≤6 cm in greatest dimension, above supraclavicular fossa | | N3 | Lymph node(s) >6 cm in greatest dimension, and/or extension below supraclavicular fossa | | Stage Grouping | TNM Combination | |---|---| | Stage I | T1N0M0 | | Stage II | T0-T2N1M0; T1N0M0 is also Stage I | | Stage III | T1N2M0; T2N0-N2M0; T3N0-N2M0 | | Stage IVA | T4N0-N2M0 | | Stage IVB | Any TN3M0 | | Stage IVC | Any T, Any N, M1 | **High-Yield:** In this case, the 4 cm mass extending beyond the nasopharynx = T3, and the 2.5 cm unilateral cervical node = N1. Therefore, **T3N1M0 = Stage III**. ### Why This Patient Is Stage III, Not Stage II or IV **Mnemonic: "T3N1 = Stage III"** — When T stage is 3 or higher with any N stage (except N3), or when N stage is 2 with T1-T3, the patient is at least Stage III. - **Not Stage II:** Stage II requires T0-T2 with N1, or T1 with N0. This patient has T3, which escalates to Stage III. - **Not Stage IV:** Stage IV requires either T4 (intracranial/orbital involvement), N3 (nodes >6 cm or below supraclavicular fossa), or M1 (distant metastases). This patient has none of these. ### Clinical Significance of Stage III NPC **Warning:** Stage III nasopharyngeal carcinoma is locally advanced and requires multimodal therapy: 1. Concurrent chemoradiotherapy (cisplatin-based) 2. Neoadjuvant chemotherapy (for high-risk disease) 3. Adjuvant chemotherapy (in selected cases) **Clinical Pearl:** Serous otitis media (conductive hearing loss) in an adult should raise suspicion for nasopharyngeal pathology, particularly malignancy. This is a classic "red flag" symptom requiring nasopharyngoscopy.